IL-17A Inhibitor Use Associated With Increased IBD Risk ...Middle East

Medscape - News
IL-17A Inhibitor Use Associated With Increased IBD Risk
The risk for inflammatory bowel disease is higher in patients with psoriasis or ankylosing spondylitis using IL-17A inhibitors than in those using apremilast, necessitating careful patient monitoring. Medscape Medical News

Hence then, the article about il 17a inhibitor use associated with increased ibd risk was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( IL-17A Inhibitor Use Associated With Increased IBD Risk )

Apple Storegoogle play

Last updated :

Also on site :